The outperformance was fueled by strong demand for infant milk formula and medical nutrition products within the Chinese market. This growth successfully offset a period of weakness in other segments, most notably in its coffee creamer business, which faced an increasingly competitive landscape in the United States. The contrasting performance across regions showcases the diversified nature of Danone’s business model and its reliance on key growth markets.

For the first half of 2025, Danone posted a recurring operating income of 1.811 billion euros ($2.09 billion), achieving a margin of 13.2% of sales, a notable improvement from the 12.7% margin recorded a year prior. These figures demonstrate the company’s ability to not only drive top-line growth but also to enhance profitability through efficient operations and strategic product mix management within the agribusiness sector.

Looking ahead, the company has reiterated its full-year 2025 forecast, which remains consistent with its mid-term ambition. Danone expects to achieve like-for-like sales growth of between 3% and 5%, with recurring operating income projected to grow at an even faster rate than sales. This optimistic outlook suggests confidence in its ongoing strategy and the continued strength of its key product categories.